These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7885972)

  • 1. Review of the symptomatic treatment of diabetic neuropathy.
    Wright JM
    Pharmacotherapy; 1994; 14(6):689-97. PubMed ID: 7885972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Painful diabetic neuropathy: treatment and future aspects.
    Ziegler D
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S52-7. PubMed ID: 18395890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the treatment and management of diabetic peripheral neuropathy.
    Donnan J; Ledger S
    CANNT J; 2006; 16(4):32-6; quiz 37-8. PubMed ID: 17252899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment of neuropathic pain].
    Ollat H
    Rev Neurol (Paris); 1992; 148(8-9):521-31. PubMed ID: 1337388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical capsaicin in the treatment of painful diabetic neuropathy.
    Levy DM; Abraham RR; Tomlinson DR
    N Engl J Med; 1991 Mar; 324(11):776-7. PubMed ID: 1997848
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies.
    Adriaensen H; Plaghki L; Mathieu C; Joffroy A; Vissers K
    Diabetes Metab Res Rev; 2005; 21(3):231-40. PubMed ID: 15858788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic therapy in peripheral diabetic polyneuropathy].
    Mihai B; Lăcătuşu C; Graur M; Cijevschi-Prelipcean C; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):332-41. PubMed ID: 20700963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
    Biesbroeck R; Bril V; Hollander P; Kabadi U; Schwartz S; Singh SP; Ward WK; Bernstein JE
    Adv Ther; 1995; 12(2):111-20. PubMed ID: 10150323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
    Tesfaye S; Vileikyte L; Rayman G; Sindrup SH; Perkins BA; Baconja M; Vinik AI; Boulton AJ;
    Diabetes Metab Res Rev; 2011 Oct; 27(7):629-38. PubMed ID: 21695762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy.
    Evans JD; Jacobs TF; Evans EW
    Ann Pharmacother; 2008 Nov; 42(11):1686-91. PubMed ID: 18940920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy in persons with diabetes.
    Handevidt F
    Clin Excell Nurse Pract; 2001; 5(1):17-20. PubMed ID: 11154389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic peripheral neuropathic pain: recognition and management.
    Cole BE
    Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin: a therapeutic option for painful diabetic neuropathy.
    Basha KM; Whitehouse FW
    Henry Ford Hosp Med J; 1991; 39(2):138-40. PubMed ID: 1890008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA; Borja NL
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy.
    Guastella V; Mick G
    Diabetes Metab; 2009 Feb; 35(1):12-9. PubMed ID: 19046917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of patients with painful diabetic neuropathy.
    Corbett CF
    Diabetes Educ; 2005; 31(4):523-4, 526-8, 530 passim. PubMed ID: 16100329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.